Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nuvo Pharmaceuticals Inc NRIFF


Primary Symbol: MRVFF

Nuvo Pharmaceuticals Inc is a Canadian focused healthcare company doing business as Miravo Healthcare with global reach and a diversified portfolio of commercial products. Its product targets several therapeutic areas, including pain, allergy, and dermatology. The company's strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets.


OTCQX:MRVFF - Post by User

Bullboard Posts
Post by HippygirL74on Feb 17, 2013 12:40am
346 Views
Post# 21001927

Even more important...

Even more important...

If Penn 2% gets BID label that would be a great advantage.  And if the tests are complete now for the concomitant use of Penn 2% with sunscreen and moisturizers on the same site and the tests are safe for patients, then this would give Penn 2% a great advantage over Volaren Gel.  Okay... if we get this, we go to $0.50 on FDA approval, otherwise, we go to $0.27 but due to the fact that there are no more pennies, we round up to $0.30.  Hippygirl.

Bullboard Posts